AGMB
AgomAb Therapeutics NV
8.70$
-22.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +330.4% | +214.1% | -29.6% | |
| – | -2.3% | -50.4% | +400.0% | |
| – | +192.3% | -131.1% | – | |
| – | – | – | -99.4% | |
| – | – | – | – | |
| – | -86.1% | +63.0% | +107.4% | |
| – | +110.8% | +22.0% | -100.3% | |
| – | – | -48.0% | -272.6% | |
| – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.